Notably, overexpression of DYRK1A in peripheral organs was related to diabetes phenotypes [76], while pharmacological inhibition of DYRK1A leads to an improved glycemic control in both mice and human cells [77,78,79]. Here, DYRK1A is linked to diabetes mellitus.